ECONOMIC IMPACT OF A 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINATION PROGRAMME IN A MEXICAN CORPORATE SETTING

被引：1
|
作者：
Huicochea-Bartelt, J. L. [1 ]
Mucino-Ortega, E. [1 ]
Vargas-Valencia, J. J. [2 ]
机构：
[1] Pfizer SA CV, Ciudad De Mexico, Mexico
[2] Econopharma Consulting SA CV, Mexico City, DF, Mexico
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 03期
关键词：
D O I：
10.1016/j.jval.2014.03.1612
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN69
引用
下载
收藏
页码：A277 / A277
页数：1
相关论文
共 50 条
  • [31] Prevnar 13, the New 13-Valent Pneumococcal Conjugate Vaccine
    Sucher, Allana J.
    Chahine, Elias B.
    Nelson, Michael
    Sucher, Brandon J.
    ANNALS OF PHARMACOTHERAPY, 2011, 45 (12) : 1516 - 1524
  • [32] Safety and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine
    Bryant, Kristina A.
    Block, Stan L.
    Baker, Sherryl A.
    Gruber, William C.
    Scott, Daniel A.
    PEDIATRICS, 2010, 125 (05) : 866 - 875
  • [33] Impacts of the 13-Valent Pneumococcal Conjugate Vaccine in Children
    Esposito, Susanna
    Principi, Nicola
    JOURNAL OF IMMUNOLOGY RESEARCH, 2015, 2015
  • [34] Factors Affecting compliance with 13-valent Pneumococcal Conjugate Catch-up Vaccination
    Sutter, Deena
    Maranich, Ashley M.
    Barnett, Scott
    Anchan, Joshua
    PEDIATRICS, 2018, 141
  • [35] Exploring the costs of a 13-valent pneumococcal conjugate vaccination program for home care patients
    Linna, Miika
    Laine, Juha
    Timonen, Leena
    Ahman, Heidi
    Htar, Myint Tin Tin
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (12) : 2089 - 2094
  • [36] Predictors of pneumococcal carriage and the effect of the 13-valent pneumococcal conjugate vaccination in the Western Australian Aboriginal population
    Deirdre A. Collins
    Anke Hoskins
    Thomas Snelling
    Kalpani Senasinghe
    Jacinta Bowman
    Natalie A. Stemberger
    Amanda J. Leach
    Deborah Lehmann
    Pneumonia, 9 (1)
  • [37] Vaccination status and immune response to 13-valent pneumococcal conjugate vaccine in asplenic individuals
    Nived, Per
    Jorgensen, Charlotte Svaerke
    Settergren, Bo
    VACCINE, 2015, 33 (14) : 1688 - 1694
  • [38] Comparing the Impact of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease Reply
    Naucler, Pontus
    Galanis, Ilias
    Morfeldt, Eva
    Darenberg, Jessica
    Ortqvist, Ake
    Henriques-Normark, Birgitta
    CLINICAL INFECTIOUS DISEASES, 2018, 66 (10) : 1642 - 1643
  • [39] Impact of the 13-Valent Pneumococcal Conjugate Vaccination in Invasive Pneumococcal Disease Incidence and Mortality (vol 59, pg 1066, 2014)
    Harboe, Z. B.
    CLINICAL INFECTIOUS DISEASES, 2014, 59 (12) : 1812 - 1812
  • [40] Effect of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis in Children
    Levy, Corinne
    Varon, Emmanuelle
    Bechet, Stephane
    Cohen, Robert
    CLINICAL INFECTIOUS DISEASES, 2016, 62 (01) : 131 - +
12345